Atypical Response in Metastatic Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: Radiographic Patterns and Clinical Value of Local Therapy

Atypical Response in Metastatic Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: Radiographic Patterns and Clinical Value of Local Therapy

Purpose: To explore the clinical characteristics, management, and survival outcomes of advanced NSCLC patients treated with PD-1/PD-L1 inhibitors who presented with an atypical response (AR). Methods: A total of 926 PD-1/PD-L1-inhibitor-treated patients with metastatic NSCLC from three academic cent...

Full description

Bibliographic Details
Main Authors: Shanshan Jiang, Jinmeng Zhang, Li Chu, Xiao Chu, Xi Yang, Yida Li, Tiantian Guo, Yue Zhou, Dayu Xu, Jiuang Mao, Zhiqin Zheng, Yulin An, Hua Sun, Huiling Dong, Silai Yu, Ruiting Ye, Jie Hu, Qian Chu, Jianjiao Ni, Zhengfei Zhu
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
NSCLC
atypical response
PD-1/PD-L1 inhibitors
local therapy
progression-free survival
overall survival
Online Access:https://www.mdpi.com/2072-6694/15/1/180

Internet

https://www.mdpi.com/2072-6694/15/1/180

Similar Items